• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AGENT; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AGENT; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 3825
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Reocclusion (1985)
Event Date 06/15/2020
Event Type  Injury  
Manufacturer Narrative
(b)(6).
 
Event Description
(b)(6) registry.It was reported that angina occurred.On (b)(6) 2020, the subject presented for index procedure.Heparin or anti-thrombin was administered.The 90% stenosed, 3.5 x 15mm target lesion was located in the left main coronary artery (lmca) extending to proximal left anterior descending (lad) artery.Timi flow was 3.The target lesion was pre-dilated with a 4.0 mm x 15 mm balloon, followed by treatment with a 4.0 mm x 20 mm agent dcb balloon with residual stenosis of 20% and timi flow of 3.The subject was discharged on aspirin and ticagrelor.On (b)(6) 2020, the subject presented with unknown symptoms and was hospitalized.Diagnosis revealed aggravation of stable angina.The next day, a cutting balloon was used to treat the 90% stenosis noted in the proximal lad target lesion resulting in 20% residual stenosis and timi flow 3.No other action was taken and the patient was discharged.On (b)(6) 2020, the event was considered resolved without sequelae.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AGENT
Type of Device
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key10606315
MDR Text Key209162728
Report Number2134265-2020-13390
Device Sequence Number1
Product Code LOX
Combination Product (y/n)N
Reporter Country CodeTW
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 09/30/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/29/2020
Device Model Number3825
Device Catalogue Number3825
Device Lot Number0908H18
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/08/2020
Initial Date FDA Received09/30/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/29/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
-
-